Your browser doesn't support javascript.
loading
Safety and efficacy of a biodegradable implant releasing tenofovir alafenamide for vaginal protection in a macaque model.
Massud, I; Krovi, A; Nishiura, K; Ruone, S; Li, L; Holder, A; Gary, J; Mills, P; Mitchell, J; Khalil, G; Pan, Y; Luecke, E; Gatto, G; Heneine, W; García-Lerma, J G; Johnson, L; van der Straten, A; Dobard, C.
Afiliação
  • Massud I; Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Krovi A; RTI International, Research Triangle Park, NC, USA.
  • Nishiura K; Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Ruone S; Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Li L; RTI International, Research Triangle Park, NC, USA.
  • Holder A; Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Gary J; Infectious Diseases Pathology Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infection Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Mills P; Comparative Medicine Branch, Division of Scientific Resources, National Center for Emerging and Zoonotic Infection Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Mitchell J; Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Khalil G; Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Pan Y; Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Luecke E; RTI International, Research Triangle Park, NC, USA.
  • Gatto G; RTI International, Research Triangle Park, NC, USA.
  • Heneine W; Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • García-Lerma JG; Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Johnson L; RTI International, Research Triangle Park, NC, USA.
  • van der Straten A; Center for AIDS Prevention Studies (CAPS), Department of Medicine, University of California San Francisco, San Francisco, CA and ASTRA Consulting, Kensington, CA, USA.
  • Dobard C; Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA, USA.
J Antimicrob Chemother ; 77(11): 2964-2971, 2022 10 28.
Article em En | MEDLINE | ID: mdl-35913838
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Problema de saúde: 1_doencas_nao_transmissiveis / 2_enfermedades_transmissibles Assunto principal: Infecções por HIV / Vírus da Imunodeficiência Símia / Fármacos Anti-HIV Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: J Antimicrob Chemother Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 1_ASSA2030 / 2_ODS3 Problema de saúde: 1_doencas_nao_transmissiveis / 2_enfermedades_transmissibles Assunto principal: Infecções por HIV / Vírus da Imunodeficiência Símia / Fármacos Anti-HIV Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: J Antimicrob Chemother Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos